Gilder Gagnon Howe & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-243,836	Closed	-$20.2M	–	280
2016 Q4	$20.2M	Sell	243,836 -199,870	-45%	-$17.2M	0.4%	68
2016 Q3	$41.1M	Sell	443,706 -17,983	-4%	-$1.69M	0.71%	47
2016 Q2	$35.9M	Sell	461,689 -9,487	-2%	-$807K	0.71%	47
2016 Q1	$38.9M	Sell	471,176 -9,220	-2%	-$750K	0.76%	33
2015 Q4	$50.3M	Sell	480,396 -4,766	-1%	-$498K	0.81%	31
2015 Q3	$51.1M	Sell	485,162 -141,338	-23%	-$18.9M	0.81%	34
2015 Q2	$85.7M	Sell	626,500 -289,936	-32%	-$35.9M	1.13%	25
2015 Q1	$114M	Sell	916,436 -146,826	-14%	-$15.6M	1.59%	16
2014 Q4	$96.1M	Sell	1,063,262 -25,748	-2%	-$2.14M	1.43%	22
2014 Q3	$78.6M	Sell	1,089,010 -12,714	-1%	-$836K	1.14%	22
2014 Q2	$68.5M	Sell	1,101,724 -3,886	-0.4%	-$235K	0.91%	28
2014 Q1	$75.4M	Sell	1,105,610 -23,125	-2%	-$1.7M	1.03%	28
2013 Q4	$79.4M	Sell	1,128,735 -132,637	-11%	-$9.01M	1.13%	27
2013 Q3	$91M	Sell	1,261,372 -26,240	-2%	-$1.74M	1.42%	19
2013 Q2	$71.8M	Buy	+1,287,612	New	+$80.2M	1.35%	21